참고문헌 (40)

1. Statistics Korea. Cause of death statistics 2011. 2012; [2screens]. Available at: URL:http://kosis.kr/ups/ups_ 01List01.jsp?pubcodeYD. Accessed Sep 20, 2012. 

2. Mannino DM, Kiriz VA. Changing the burden of COPD mortality. Int J Chron Obstruct Pulmon Dis. 2006;1(3):219-33. 

   상세보기

3. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002;121:121S-26S. 

   상세보기

4. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6): 932-46. 

   상세보기

5. Barnes PJ, Hansel TT. Prospects for new drugs for chronic obstructive pulmonary disease. Lancet. 2004; 364(9438):985-96. 

   상세보기

6. Jung SK, Jung HJ, Kim JD, Choi HY, Park MY, Park YC, et al. Pye-gye-nae-gwa-hak. Seoul: Nado. 2011:510-1. 

7. Lee H, Kim Y, Kim HJ, Park S, Jang YP, Jung S, et al. Herbal Formula, PM014, Attenuates Lung Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease. Evid Based Complement Alternat Med. 2012;2012:769830. Epub 2012 Jun 12. 

   상세보기

8. Lee JG, Yang SY, Kim MH, Namgung U, Park YC. Protective effects of Socheongryong-tang on Elastase-Induced Lung Injury. J Korean Oriental Med. 2011;32(4):83-99. 

9. Yoon JM, Park YC. Protective effects of Seonpyejeongcheon-tang on Elastase-induced Lung Injury. J Korean Oriental Med. 2010;31(1):84-101. 

10. Choi HJ, Bang NY, Song BW, Kim NJ, Rhyu BH. Survey on the preference for the dosage forms of oriental herbal medicine. Kyunghee Medicine. 2004;20(1):46-57. 

11. Derendorf H, Nave R, Drollmann A, Cerasoli F, Wurst W. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J. 2006;28(5):1042-50. 

    상세보기

12. Courrier HM, Butz N, Vandamme TF. Pulmonary drug delivery systems: recent developments and prospects. Crit Rev Ther Drug Carrier Syst. 2002;19(4-5):425-98. 

    상세보기

13. Zhang J. Shang-han-za-bing-lun. Shijiazhuang. Hebei Kezue Jishu Chubanshe. 1994. p.27. 

14. Jung S, Cho SJ, Moon KI, Kim HW, Kim BY, Cho SI. Effects of Socheongryong-Tang on Immunoglobulin Production in Asthmatic Mice. Kor. J. Herbology. 2008;23(1):23-8. 

15. Kim KY, Lee JH, Kim YJ, Choi SY, Kim TH, Lyu YS, et al. Anti-allergic effects of Socheongyoung-tang on RBL-2H3 mast cell and mice-mediated allergy model. Korean J. Oriental Physiology & Pathology. 2007;21(5):1260-70. 

    원문보기 상세보기

16. Hwang WS, Lee JS, Choi JY, Jung HJ, Rhee HK, Jung SK. Two Cases of Chronic Sinusitis with Asthma Improved by Socheongryong-tang. J Korean Oriental Med. 2003;24(1):207-12. 

17. Jung SK, Heo TS, Hwang WS, Ju CY, Kim YW, Jung HJ. The Effects of Sochongryong-tang on Serum IL-4, IL-5, and IFN- $\gamma$ in asthmatic Patients. J Korean Oriental Med. 2002;23(2): 70-7. 

18. Ibrahim BM, Jun SW, Lee MY, Kang SH, Yeo Y. Development of inhalable dry powder formulation of basic fibroblast growth factor. Int J Pharm. 2010;385(1-2):66-72. 

    상세보기

19. Thiel CG. Cascade impactor data and the lognormal distribution: nonlinear regression for a better fit. J Aerosol Med. 2002;15(4):369-78. 

    상세보기

20. Nemzek JA, Bolgos GL, Williams BA, Remick DG. Differences in normal values for murine white blood cell counts and other hematological parameters based on sampling site. Inflamm Res. 2001;50(10):523-7. 

    상세보기

21. Hillery AM, Lloyd AW, Swarbrick J. Drug delivery and targeting; for pharmacists and pharmaceutical scientists. London:Taylor and Francis. 2001:2. 

22. Tayab ZR, Hochhaus G. Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery system s.Expert Opin Drug Deliv. 2005;2(3):519-32. 

    상세보기

23. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-55. 

    상세보기

24. Geller DE. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Respir Care. 2005;50(10):1313-21. 

    상세보기

25. Borgstrom L. On the use of dry powder inhalers in situations perceived as constrained. J Aerosol Med. 2001;14(3):281-7. 

    상세보기

26. Yang Y, Tsifansky MD, Shin S, Lin Q, Yeo Y. Mannitol-guided delivery of Ciprofloxacin in artificial cystic fibrosis mucus model. Biotechnol Bioeng. 2011;108(6):1441-9. 

    상세보기

27. Yang Y, Tsifansky MD, Wu CJ, Yang HI, Schmidt G, Yeo Y. Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis. Pharm Res. 2010;27(1): 151-60. 

    상세보기

28. Lipworth BJ. Targets for inhaled treatment. Respir Med. 2000;94:S13-6. 

    상세보기

29. Azarmi S, Lobenberg R, Roa WH, Tai S, Finlay WH. Formulation and in vivo evaluation of effervescent inhalable carrier particles for pulmonary delivery of nanoparticles. Drug Dev Ind Pharm. 2008;34(9):943-7. 

    상세보기

30. Molfino NA, Jeffery PK. Chronic obstructive pulmonary disease: Histopathology, inflammation and potential therapies. Pulm Pharmacol Ther. 2007;20(5):462-72. 

    상세보기

31. Yoo CG. Pathogenesis and pathophysiology of COPD. The Korean Journal of Medicine. 2009;77:383-400. 

32. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med. 1974;291(15):755-8. 

    상세보기

33. Schaberg T, Haller H, Rau M, Kaiser D, Fassbender M, Lode H. Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers. Eur Respir J. 1992;5(4):387-93. 

    상세보기

34. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2008;295(1): L1-15 

    상세보기

35. Wright JL, Sun JP. Effect of smoking cessation on pulmonary and cardiovascular function and structure: analysis of guinea pig model. J Appl Physiol. 1994;76(5):2163-8. 

    상세보기

36. Yang IA, Clarke MS, Sim EH, Fong KM. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;7:CD002991. 

37. Tanino M, Betsuyaku T, Takeyabu K, Tanino Y, Yamaguchi E, Miyamoto K, et al. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax. 2002;57(5):405-11. 

    상세보기

38. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153 (2):530-4. 

    상세보기

39. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res. 2006;7:53. 

    상세보기

40. Foronjy R, D'Armiento J. The role of collagenase in emphysema. Respir Res. 2001;2(6):348-52. 

    상세보기

저자의 다른 논문 :

이응석 (3) 한종민 (6) 김민희 (8) 남궁욱 (18) 여윤 (1) 박양춘 (136)